News Image

Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe

Provided By GlobeNewswire

Last update: Jun 24, 2025

-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow --

Read more at globenewswire.com

AMARIN CORP PLC -ADR

NASDAQ:AMRN (7/25/2025, 4:30:01 PM)

15.385

-0.12 (-0.74%)



Find more stocks in the Stock Screener

Follow ChartMill for more